Looking at the timeline of other drugs that received an EUA, we could receive one as early as this week. If the FDA does grant us one, what do you think the impact will be? Will there be sales immediately? Will other countries start to ask for leronlimab? Will manufacturing start to increase? Will OWS step in? What will this company's first "approval" do to our SP?

I know its a lot of questions, but I am more of an ETF and let professionals handle my money kind of guy. Over a year ago my doctor friend told be to buy this stock for HIV and I did and haven't sold a single share since. So if any experienced biotech investors can guide me through what a conditional EUA would look like for this small company I would be very grateful.